We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

273 hedge funds and large institutions have $2.67B invested in Pacira BioSciences in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 116 increasing their positions, 83 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 83

1.84% more ownership

Funds ownership: 107.74% → 109.57% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

4% less funds holding

Funds holding: 284 → 273 (-11)

5% less capital invested

Capital invested by funds: $2.82B → $2.67B (-$150M)

27% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 30

43% less call options, than puts

Call options by funds: $3.31M | Put options by funds: $5.79M

Holders
273
Holders Change
-11
Holders Change %
-3.87%
% of All Funds
4.7%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
22
Increased
116
Reduced
83
Closed
30
Calls
$3.31M
Puts
$5.79M
Net Calls
-$2.48M
Net Calls Change
+$10.2M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$55.6M
2
Millennium Management
Millennium Management
New York
+$24.3M
3
Jennison Associates
Jennison Associates
New York
+$21.3M
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$13.3M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.9M

Top Sellers

Rank Fund Capital Flow
1
Macquarie Group
Macquarie Group
Australia
-$35M
2
PC
Paulson & Co
New York
-$20.4M
3
Renaissance Technologies
Renaissance Technologies
New York
-$11.8M
4
SCM
Spyglass Capital Management
California
-$11.6M
5
GLA
Great Lakes Advisors
Illinois
-$8.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
DIA
101
Dana Investment Advisors
Wisconsin
$1.89M -$131K -2,358 -6%
SSA
102
Schonfeld Strategic Advisors
New York
$1.84M -$171K -3,082 -8%
Comerica Bank
103
Comerica Bank
Texas
$1.83M -$203K -3,650 -9%
MAM
104
Martingale Asset Management
Massachusetts
$1.77M +$195K +3,501 +12%
CNAM
105
Campbell Newman Asset Management
Wisconsin
$1.75M +$44K +792 +2%
TPSF
106
Texas Permanent School Fund
Texas
$1.75M +$6.56K +118 +0.4%
SOADOR
107
State of Alaska Department of Revenue
Alaska
$1.69M -$147K -2,637 -8%
TRSOTSOK
108
Teachers Retirement System of the State of Kentucky
Kentucky
$1.62M +$1.69M +30,439 New
JG
109
Jefferies Group
New York
$1.59M +$1.25M +22,454 +299%
SG
110
Stonnington Group
California
$1.57M +$357K +6,422 +28%
Citigroup
111
Citigroup
New York
$1.55M +$35.5K +639 +2%
DekaBank Deutsche Girozentrale
112
DekaBank Deutsche Girozentrale
Germany
$1.48M – – –
State of Tennessee, Department of Treasury
113
State of Tennessee, Department of Treasury
Tennessee
$1.41M +$261K +4,693 +21%
CSS
114
Cubist Systematic Strategies
Connecticut
$1.39M +$902K +16,229 +163%
Envestnet Asset Management
115
Envestnet Asset Management
Illinois
$1.37M -$6.9K -124 -0.5%
PCM
116
Princeton Capital Management
New Jersey
$1.35M +$50.7K +911 +4%
OF
117
Outfitter Financial
Maine
$1.35M +$47.5K +855 +3%
N
118
Natixis
France
$1.34M +$1.4M +25,250 New
FNBOO
119
First National Bank of Omaha
Nebraska
$1.34M +$10.5K +188 +0.8%
AIG
120
American International Group
New York
$1.31M +$16.5K +296 +1%
PFM
121
Premier Fund Managers
United Kingdom
$1.26M -$7.84M -141,000 -86%
MIM
122
MetLife Investment Management
New Jersey
$1.26M – – –
JMPWA
123
JP Morgan Private Wealth Advisors
California
$1.25M +$200K +3,595 +18%
PNC Financial Services Group
124
PNC Financial Services Group
Pennsylvania
$1.24M +$23.6K +425 +2%
AB
125
Amalgamated Bank
New York
$1.19M +$32.4K +582 +3%
3 4
5
6 7

PCRX Hedge Fund Activity: Q3 2022 in Review

273 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2022, worth a combined $2.67B — down 5.3% from $2.82B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of PCRX and 22 opened new positions — a net loss of 8 holders — while 83 trimmed existing stakes and 116 added.

The largest buyer was Armistice Capital, adding an estimated $55.6M. The largest seller was Macquarie Group, cutting an estimated $35M.

  • 273 institutional investors held Pacira BioSciences (PCRX) as of Q3 2022, down from 284 in Q2 2022.
  • Funds reported $2.67B of Pacira BioSciences stock for Q3 2022, down 5.3% quarter-over-quarter.
  • 22 funds opened new Pacira BioSciences positions in Q3 2022 and 30 closed out, a net change of -8 holders.
  • The largest Pacira BioSciences buyer in Q3 2022 was Armistice Capital, an estimated $55.6M added.
  • The largest Pacira BioSciences seller in Q3 2022 was Macquarie Group, an estimated $35M sold.

Based on aggregated 13F filings for Q3 2022.